 |
| |
New March issue
Our digital magazine this month examines the technical challenges of pharmaceutical filtration, as well as counterfeit medicines and drug impurities. More... |
 |
|
| |
Counterfeits increasing in Europe
Our column crunch looks at the growing problem of counterfeit medicines in European supply chains, as well as the new business model that could pose a risk to pharmaceutical contract manufacturing organisations. More... |
 |
|
| |
Pores for thought
The therapeutic responses of vaccines can be boosted using adjuvants, but this approach presents many challenges. Our roundtable of experts put their heads together to look at solutions to some of the problems in this area. More... |
 |
|
| |
European guidance on genetic variability
Our news roundup brings you up to date with the EMA's guidance on genetic variability, Merck KGaA's warning letters, Pfizer's Chinese deal for generic medicines and South Africa's upcoming API plant. More... |
 |
|
| |
Ensuring products meet the right standards
Medicines must comply with approved specifications. However, final product testing is not always required in certain circumstances. An expert from Boehringer Ingelheim explains how parametric release and real-time release testing use manufacturing data to ensure that a product is made to defined standards. More... |
 |
|
| Event Profile |
| PDA |
Parenteral Packaging, March 13-15, Berlin | Germany
PDA organizes this conference to address the technical and regulatory issues related to parenteral packaging. Chemical, physical and microbiological aspects will be considered and current regulatory challenges will be discussed. Two Training Courses on Container Closure Development or Selection and Utilization of Glass Containers in Pharmaceutical Packaging will be given
 Read more
|
